These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15797249)

  • 21. Quantitative analysis of substrate specificity of haloalkane dehalogenase LinB from Sphingomonas paucimobilis UT26.
    Kmunícek J; Hynková K; Jedlicka T; Nagata Y; Negri A; Gago F; Wade RC; Damborský J
    Biochemistry; 2005 Mar; 44(9):3390-401. PubMed ID: 15736949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of the substrate binding site of human leukocyte chymotrypsin (cathepsin G) using tripeptidyl-p-nitroanilide substrates.
    Szabó G; Tözsér J; Aurell L; Elödi P
    Acta Biochim Biophys Hung; 1986; 21(4):349-62. PubMed ID: 3109179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders.
    Gorrell MD
    Clin Sci (Lond); 2005 Apr; 108(4):277-92. PubMed ID: 15584901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents.
    Pei Z
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):512-32. PubMed ID: 18600568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
    Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
    Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors.
    Zhao G; Taunk PC; Magnin DR; Simpkins LM; Robl JA; Wang A; Robertson JG; Marcinkeviciene J; Sitkoff DF; Parker RA; Kirby MS; Hamann LG
    Bioorg Med Chem Lett; 2005 Sep; 15(18):3992-5. PubMed ID: 16046120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Structure-activity relationship in the enzymatic hydrolysis of dipeptide aryl amides by dipeptidyl peptidase IV].
    Barth A; Mager H; Fischer G; Neubert K; Schwarz G
    Acta Biol Med Ger; 1980; 39(11-12):1129-42. PubMed ID: 7018141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
    Fang B; Boross PI; Tozser J; Weber IT
    J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus.
    Triplitt C; Wright A; Chiquette E
    Pharmacotherapy; 2006 Mar; 26(3):360-74. PubMed ID: 16503716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization.
    Meadows SA; Edosada CY; Mayeda M; Tran T; Quan C; Raab H; Wiesmann C; Wolf BB
    Biochemistry; 2007 Apr; 46(15):4598-605. PubMed ID: 17381073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus.
    McIntosh CH; Demuth HU; Kim SJ; Pospisilik JA; Pederson RA
    Int J Biochem Cell Biol; 2006; 38(5-6):860-72. PubMed ID: 16442340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysis.
    Bergstrom RC; Coombs GS; Ye S; Madison EL; Goldsmith EJ; Corey DR
    Biochemistry; 2003 May; 42(18):5395-402. PubMed ID: 12731881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes.
    Hui H; Zhao X; Perfetti R
    Diabetes Metab Res Rev; 2005; 21(4):313-31. PubMed ID: 15852457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes.
    Deacon CF; Holst JJ
    Int J Biochem Cell Biol; 2006; 38(5-6):831-44. PubMed ID: 16242377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Substrate specificity of the serine proteinase from Bacillus subtilis, strain 72].
    Gololobov MIu; Morozova IP; Voiushina TL; Timokhina EA; Stepanov VM
    Biokhimiia; 1991 Feb; 56(2):230-40. PubMed ID: 1908319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a recombinantly expressed proteinase K-like enzyme from a psychrotrophic Serratia sp.
    Larsen AN; Moe E; Helland R; Gjellesvik DR; Willassen NP
    FEBS J; 2006 Jan; 273(1):47-60. PubMed ID: 16367747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase.
    Kotzia GA; Labrou NE
    J Biotechnol; 2005 Oct; 119(4):309-23. PubMed ID: 15951039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.